The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / REF and AF Partner to Provide an Additional “Bridge Funding”

REF and AF Partner to Provide an Additional “Bridge Funding”

July 1, 2008 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Fostering promising investigators is imperative to the future of rheumatology, so when the ACR Research and Education Foundation (REF) board of directors discovered that outstanding applicants were not being funded through the National Institutes of Health (NIH) K-series grant program (the NIH’s career development award program) due to budgetary constraints, the REF quickly called a meeting with the Arthritis Foundation (AF) and the NIH to discuss a solution.

You Might Also Like
  • Bridge Funding Award Keeps Researcher on the Path to Her Passion
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • In America’s Recession, the REF Remains Strong
Explore This Issue
July 2008
Also By This Author
  • Practical, Diverse Knowledge: A Preview of 2019’s ARP Sessions

“The board of directors recognizes the need for the REF to work closely with the AF and the NIH in our joint mission to assure that promising young physician scientists working in clinical and basic research in the rheumatic diseases succeed,” said Leslie Crofford, MD, president of the REF. Therefore, it was agreed that the REF and AF would partner to provide the support needed.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Through an accelerated Request for Applications and application review process administered by the REF, four promising investigators will receive a bridge funding award for up to 12 months, providing them with protected time to continue research, as well as time to reapply for a NIH K-series award.

“These awards are a pragmatic recognition that, in the current budget environment, even the best applicants may need to apply to NIH more than once to successfully secure their career development awards. What we cannot allow is for our young investigators to get discouraged or have their time diverted to other activities during the re-application process. The bridge funding award gives our young investigators the best chance to continue the momentum of their academic careers.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For more information about the REF and the awards and grants program, visit www.rheumatology.org/REF.

Filed Under: Education & Training, From the College, Professional Topics Tagged With: AC&R, Funding, Grants, National Institutes of Health, NIH, REF, REF News, Rheumatoid arthritisIssue: July 2008

You Might Also Like:
  • Bridge Funding Award Keeps Researcher on the Path to Her Passion
  • ACR Research and Education Foundation Meets with NIAMS and AF to Discuss Funding
  • In America’s Recession, the REF Remains Strong
  • Health Professional Careers in Rheumatology Research

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.